BPRN vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BPRN exhibits weak financial health with a Piotroski F-Score of 3/9, signaling significant concerns in profitability, leverage, and operating efficiency. Despite this, the stock shows strong revenue growth (52.4% YoY) and impressive earnings surprises, with a recent YoY EPS growth of 50.8% and a staggering Q/Q EPS jump of 850%. Valuation appears reasonable relative to peers with a P/E of 14.21 vs. sector average of 21.55, and a Price/Book of 0.94 suggesting near-book value trading. However, bearish insider activity, low technical trend (10/100), and lack of key financial data (Altman Z-Score, debt/equity, cash flow) constrain confidence in sustained outperformance.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BPRN vs BRK-B: Head-to-Head Comparison
This page compares Princeton Bancorp, Inc. (BPRN) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.